TVRD - מחיר למכירות Cara Therapeutics, Inc.

Cara Therapeutics Inc (TVRD) operates in an aggressive environment where patent loss risks and pressure from industry behemoths create serious challenges. The company is currently radically cutting R&D expenses in an effort to preserve capital following trial failures. Simultaneously, the team attracts top biochemists through a flexible culture and stock options. This P/S chart illustrates the business valuation dynamics, where the value 15.10 describes the current level of the market multiple.
פילוחים אנליטיים של חברת Cara Corp (TVRD)

The P/S ratio determines the market value of a business relative to its annual turnover, allowing an investor to assess the premium paid per unit of generated revenue. By analyzing the price-to-sales ratio of Cara Therapeutics Inc (TVRD), one can understand how the market values the potential of renal pruritus treatments developed in collaboration with Vifor Pharma, which confirms the company's fundamental stability.